These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29440590)

  • 1. PDGFR-α, PDGFR-β, VEGFR-2 and CD117 expression in canine mammary tumours and evaluation of the in vitro effects of toceranib phosphate in neoplastic mammary cell lines.
    Gattino F; Maniscalco L; Iussich S; Biasato I; Martano M; Morello E; Gola C; Millán Ruiz Y; Saeki N; Buracco P; Martín de Las Mulas J; De Maria R
    Vet Rec; 2018 Aug; 183(7):221. PubMed ID: 29440590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of expression and function of vascular endothelial growth factor receptor 2, platelet derived growth factor receptors-alpha and -beta, KIT, and RET in canine apocrine gland anal sac adenocarcinoma and thyroid carcinoma.
    Urie BK; Russell DS; Kisseberth WC; London CA
    BMC Vet Res; 2012 May; 8():67. PubMed ID: 22630170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro.
    Milovancev M; Helfand SC; Marley K; Goodall CP; Löhr CV; Bracha S
    BMC Vet Res; 2016 Jun; 12():85. PubMed ID: 27259510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of VEGFR and PDGFR-α/-β in 187 canine nasal carcinomas.
    Gramer I; Killick D; Scase T; Chandry D; Marrington M; Blackwood L
    Vet Comp Oncol; 2017 Sep; 15(3):1041-1050. PubMed ID: 27278115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemistry Screening of Different Tyrosine Kinase Receptors in Canine Solid Tumors-Part I: Proposal of a Receptor Panel to Predict Therapies.
    Dos Anjos DS; Civa PAS; Werner J; Vicente IST; Fonseca-Alves CE
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of platelet-derived growth factor and its receptors in spontaneous canine hemangiosarcoma and cutaneous hemangioma.
    Asa SA; Murai A; Murakami M; Hoshino Y; Mori T; Maruo K; Khater A; El-Sawak A; el-Aziz EA; Yanai T; Sakai H
    Histol Histopathol; 2012 May; 27(5):601-7. PubMed ID: 22419024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor tyrosine kinase expression and phosphorylation in canine nasal carcinoma.
    Hocker SE; Higginbotham ML; Schermerhorn T; Henningson J
    Res Vet Sci; 2017 Dec; 115():484-489. PubMed ID: 28783596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and activation of platelet-derived growth factor β receptor, mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) and extracellular signal-regulated kinase (ERK) in canine mammary tumours.
    Altamura G; Uberti BD; Galiero G; Martano M; Pirro A; Russo M; Borzacchiello G
    Res Vet Sci; 2017 Feb; 110():29-33. PubMed ID: 28159233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGFR-2 expression in malignant tumours of the canine mammary gland: a prospective survival study.
    Santos A; Lopes C; Gärtner F; Matos AJ
    Vet Comp Oncol; 2016 Sep; 14(3):e83-92. PubMed ID: 24976305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of receptor tyrosine kinase targets PDGFR-β, VEGFR2 and KIT in canine transitional cell carcinoma.
    Walters L; Martin O; Price J; Sula MM
    Vet Comp Oncol; 2018 Mar; 16(1):E117-E122. PubMed ID: 28884928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the therapeutic potential of masitinib and expression of its specific targets c-Kit, PDGFR-α, PDGFR-β, and Lyn in canine prostate cancer cell lines.
    Klose K; Packeiser EM; Granados-Soler JL; Hewicker-Trautwein M; Murua Escobar H; Nolte I
    Vet Comp Oncol; 2022 Sep; 20(3):641-652. PubMed ID: 35384248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of expression of VEGFR2, KIT, PDGFR-β, and CDK4 in canine urothelial carcinoma.
    Setyo LC; Donahoe SL; Shearer PL; Wang P; Krockenberger MB
    J Vet Diagn Invest; 2023 Mar; 35(2):109-115. PubMed ID: 36648148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of receptor tyrosine kinase activation and biological activity of toceranib phosphate in canine urothelial carcinoma cell lines.
    Korec DI; Louke DS; Breitbach JT; Geisler JA; Husbands BD; Fenger JM
    BMC Vet Res; 2021 Oct; 17(1):320. PubMed ID: 34600548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting prognostic implications of platelet-derived growth factor receptor-β and vascular endothelial growth factor receptor-2 in patients with angiosarcoma.
    Yonemori K; Tsuta K; Ando M; Hirakawa A; Hatanaka Y; Matsuno Y; Chuman H; Yamazaki N; Fujiwara Y; Hasegawa T
    Ann Surg Oncol; 2011 Oct; 18(10):2841-50. PubMed ID: 21409488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression frequency of c-kit isoforms and its prognostic potential in canine mammary tumours.
    Chen YC; Liao JW; Chang SC; Hsu WL
    Vet Comp Oncol; 2020 Sep; 18(3):303-314. PubMed ID: 31652393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
    Wilczynski SP; Chen YY; Chen W; Howell SB; Shively JE; Alberts DS
    Hum Pathol; 2005 Mar; 36(3):242-9. PubMed ID: 15791568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of platelet-derived growth factor receptor-α/ß, vascular endothelial growth factor receptor-2, c-Abl, and c-Kit in canine granulomatous meningoencephalitis and necrotizing encephalitis.
    Song JH; Yu DH; Hwang TS; Seung BJ; Sur JH; Kim YJ; Jung DI
    Vet Med Sci; 2020 Nov; 6(4):965-974. PubMed ID: 32585777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical and mutational analysis of PDGF and PDGFR in desmoid tumours: is there a role for tyrosine kinase inhibitors in c-kit-negative desmoid tumours?
    Liegl B; Leithner A; Bauernhofer T; Windhager R; Guelly C; Regauer S; Beham A
    Histopathology; 2006 Dec; 49(6):576-81. PubMed ID: 17163842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kit and PDGFR-alpha activities are necessary for Notch4/Int3-induced tumorigenesis.
    Raafat A; Zoltan-Jones A; Strizzi L; Bargo S; Kimura K; Salomon D; Callahan R
    Oncogene; 2007 Feb; 26(5):662-72. PubMed ID: 16878155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of ponatinib in vitro effect in three canine mast cell tumor cell lines expressing FGFR-1, PDGFR-α, and VEGFR-2.
    Fisher CJ; Lejeune AT; Dark MJ; Hernandez OM; Shiomitsu K
    Vet J; 2021 Mar; 269():105621. PubMed ID: 33593493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.